Univariate | Multivariate | ||||
---|---|---|---|---|---|
Variable | r | p Value | Coefficient | CI | p Value |
Follow up LVEF was 72–(0.29×LVESVrest)–8.5 for CR− or 72–(0.29×LVESVrest) for CR+ patients (model r2 = 0.33, p<0.0001). Age, male sex, functional capacity (METS or Vo2max), peak RPP, peak heart rate, peak systolic blood pressure, atrial fibrillation, pulmonary hypertension, weight, ACE inhibitor use, LVEDD, LVESD, EFrest, and LVEDVexe were not significantly correlated with follow up LVEF on bivariate analysis. | |||||
Intercept | NA | NA | 72 | 63 to 81 | <0.0001 |
LVESVrest | −0.42 | 0.007 | −0.29 | −0.47 to −0.11 | 0.002 |
CR | 0.41 | 0.008 | −8.5 | −14.3 to −2.6 | 0.006 |
LVEDVrest | −0.37 | 0.02 | NA | NA | NA |
LVESVexe | −0.35 | 0.03 | NA | NA | NA |
EFexe | 0.34 | 0.03 | NA | NA | NA |